Target intelligence / Profile preview

Tissue repair and wound healing pathways

Molecular classification
Signaling pathway, Biological process
01

Overview

Tissue repair and wound healing pathways encompass a coordinated sequence of cellular and molecular events designed to restore tissue integrity following injury [1]. This process is categorized into four distinct yet overlapping phases: hemostasis, inflammation, proliferation, and remodeling [2]. It involves a diverse array of cell types, including platelets, neutrophils, macrophages, fibroblasts, and endothelial cells, which communicate via complex signaling networks involving growth factors like PDGF and TGF-beta [3]. Dysregulation of these pathways is a hallmark of various pathologies, ranging from chronic non-healing ulcers in diabetic patients to excessive scarring and systemic fibrosis [1, 2]. Pharmacological intervention typically targets specific components of these pathways, such as growth factor receptors or inflammatory mediators, to promote efficient repair and minimize adverse outcomes [3].

Other names
Wound healing cascadeTissue regeneration pathwaysCutaneous wound healing process
02

Mechanism of action

Modulation of growth factor signaling (e.g., PDGF receptor activation), regulation of inflammatory cytokine release, enzymatic debridement of necrotic tissue, and stimulation of extracellular matrix deposition [1, 3].

03

Biological functions

HemostasisInflammationCell proliferationAngiogenesisExtracellular matrix remodelingRe-epithelialization
04

Disease associations

Chronic woundsDiabetic foot ulcerFibrosisHypertrophic scarringKeloidsVenous leg ulcers
05

Safety considerations

Potential for oncogenic transformation with exogenous growth factors (e.g., black box warning for Becaplermin) [FDA]Risk of systemic absorption and toxicityDevelopment of hypertrophic scars or keloidsSecondary infections
06

Interacting drugs

Becaplermin

4 more in the full profile.

07

Biomarkers

Matrix metalloproteinase-9 (MMP-9)Vascular endothelial growth factor (VEGF)Interleukin-6 (IL-6)Transforming growth factor beta 1 (TGF-beta 1)

Beyond the preview

Go deeper on Tissue repair and wound healing pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue repair and wound healing pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call